{"transactions":[{"id":962105,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-19T11:39:39.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)"}],"balance_after":18280,"derivative":{"exercise_price":1.29,"expiration_date":"2030-12-18","underlying":"Common shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001213900-25-123628","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390025123628/ownership.xml","form_type":"4"}},{"id":965170,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Expiration)","published_at":"2025-12-17T12:16:23.000Z","date":"2025-12-15","kind":"other","planned":false,"acquired":false,"shares":70,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00"}],"balance_after":5280,"derivative":{"exercise_price":1397.97,"exercise_date":"2020-12-16","expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":70},"source":{"system":"sec-edgar","filing":"0001213900-25-122641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390025122641/ownership.xml","form_type":"4"}},{"id":1322922,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-23T09:21:36.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split."}],"balance_after":5350,"derivative":{"exercise_price":4.14,"expiration_date":"2029-12-19","underlying":"Common shares","underlying_shares":2750},"source":{"system":"sec-edgar","filing":"0001213900-24-111554","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390024111554/ownership.xml","form_type":"4"}},{"id":1500569,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Expiration)","published_at":"2024-05-28T16:26:47.000Z","date":"2024-05-27","kind":"other","planned":false,"acquired":false,"shares":545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00"}],"balance_after":52000,"derivative":{"exercise_price":263.18,"exercise_date":"2019-05-27","expiration_date":"2024-05-27","underlying":"Common shares","underlying_shares":545},"source":{"system":"sec-edgar","filing":"0001213900-24-047095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390024047095/ownership.xml","form_type":"4"}},{"id":1597089,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Expiration)","published_at":"2024-03-05T15:20:38.000Z","date":"2024-03-04","kind":"other","planned":false,"acquired":false,"shares":309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$495 using an exchange rate of C$1.3572 = $US1.00"}],"balance_after":52545,"derivative":{"exercise_price":364.72,"exercise_date":"2019-03-04","expiration_date":"2024-03-04","underlying":"Common shares","underlying_shares":309},"source":{"system":"sec-edgar","filing":"0001213900-24-020087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390024020087/ownership.xml","form_type":"4"}},{"id":1700188,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-26T13:07:44.000Z","date":"2023-12-23","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month)."}],"balance_after":52854,"derivative":{"exercise_price":0.37,"expiration_date":"2028-12-22","underlying":"Common shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001213900-23-098490","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390023098490/ownership.xml","form_type":"4"}},{"id":1792044,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Expiration)","published_at":"2023-08-31T17:22:15.000Z","date":"2023-08-31","kind":"other","planned":false,"acquired":false,"shares":327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$676.50 using an exchange rate of C$1.3531 = $US1.00"}],"balance_after":7854,"derivative":{"exercise_price":499.96,"exercise_date":"2018-08-31","expiration_date":"2023-08-31","underlying":"Common shares","underlying_shares":327},"source":{"system":"sec-edgar","filing":"0001213900-23-072856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390023072856/ownership.xml","form_type":"4"}},{"id":1891696,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Expiration)","published_at":"2023-05-16T18:00:00.000Z","date":"2023-05-16","kind":"other","planned":false,"acquired":false,"shares":152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$841.50 using an exchange rate of C$1.3487 = $US1.00"}],"balance_after":8181,"derivative":{"exercise_price":623.93,"exercise_date":"2018-05-16","expiration_date":"2023-05-16","underlying":"Common shares","underlying_shares":152},"source":{"system":"sec-edgar","filing":"0001213900-23-040579","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390023040579/ownership.xml","form_type":"4"}},{"id":1961190,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Expiration)","published_at":"2023-03-09T15:45:53.000Z","date":"2023-03-08","kind":"other","acquired":false,"shares":545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$1,278.75 using an exchange rate of C$1.3785 = $US1.00"}],"balance_after":8333,"derivative":{"exercise_price":927.64,"exercise_date":"2018-03-08","expiration_date":"2023-03-08","underlying":"Common shares","underlying_shares":545},"source":{"system":"sec-edgar","filing":"0001213900-23-018869","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390023018869/ownership.xml","form_type":"4"}},{"id":2081839,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-19T16:49:31.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":8878,"derivative":{"exercise_price":1.78,"expiration_date":"2027-12-15","underlying":"Common shares","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001213900-22-080968","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390022080968/ownership.xml","form_type":"4"}},{"id":2110500,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-11-18T19:35:00.000Z","date":"2022-11-14","kind":"disposition_to_issuer","acquired":false,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 4,200 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 4,678 derivative securities of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 4,200 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 4,678 derivative securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the Issuer's common stock was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 4,200 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 4,678 derivative securities of the Issuer."}],"balance_after":4678,"derivative":{"exercise_price":2.78,"expiration_date":"2027-11-13","underlying":"Common shares","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001213900-22-073944","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390022073944/ownership.xml","form_type":"4/A","original_submission_date":"2022-11-15"}},{"id":2116348,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-11-15T19:48:48.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":8878,"derivative":{"exercise_price":2.78,"expiration_date":"2027-11-13","underlying":"Common shares","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001213900-22-072922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390022072922/ownership.xml","form_type":"4"}},{"id":2539482,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-19T18:22:22.000Z","date":"2021-10-18","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 10/18/2021 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."}],"balance_after":116969,"derivative":{"exercise_price":1.4,"expiration_date":"2026-10-17","underlying":"Common shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-21-053585","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390021053585/ownership.xml","form_type":"4"}},{"id":2938170,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71101,"kind":"person","name":"HSU ERIC C","position":1,"cik":"0001817867","reported_name":"HSU ERIC C","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Pre-Clinical Res/Dev"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-18T06:18:40.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted on 12/16/2020 and will vest as follows: 25% on 6/16/2021; 25% on 12/16/2021; 25% on 6/16/2022; and 25% on 12/16/2022."}],"balance_after":35000,"derivative":{"exercise_price":3.02,"expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-20-043364","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817867/000121390020043364/ownership.xml","form_type":"4"}}]}